Atlas Trials

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

Clinical trial NCT06698679 · RECRUITING

Trial details

NCT number
NCT06698679
Sponsor
Shengjing Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2024-11-15
Primary completion
2031-06-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.